Fresenius Medical Care AG & Co KGaA ST buy GMSE
Summary
This prediction ended on 11.05.24 with a price of €40.50. With a performance of -9.50%, the BUY prediction for Fresenius Medical Care AG & Co KGaA ST by GMSE closed slightly in the red. Dividends of €1.19 are taken into consideration when calculating the performance. GMSE has 50% into this predictionFresenius Medical Care is a leading global provider of dialysis products, services and care, particularly for patients with chronic kidney disease. It operates in over 120 countries and cares for over 345,000 patients worldwide. The company specializes in renal care, manufacturing and distributing products related to dialysis and providing clinical care as well as education and support services for patients with kidney disease. Fresenius Medical Care has been listed on the Frankfurt Stock Exchange since 1996 and on the New York Stock Exchange since 1997. Its symbol, FMCQF, represents its over-the-counter (OTC) stock symbol in the United States.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Fresenius Medical Care AG & Co KGaA ST | -0.858% | -0.858% | -21.962% |
iShares Core DAX® | 1.663% | 6.945% | 18.807% |
iShares Nasdaq 100 | 1.261% | 4.883% | 23.667% |
iShares Nikkei 225® | 0.654% | 10.007% | 15.047% |
iShares S&P 500 | 1.403% | 4.350% | 23.305% |
Comments by GMSE for this prediction
In the thread Fresenius Medical Care AG & Co KGaA ST diskutieren
In the thread Trading Fresenius Medical Care AG & Co KGaA ST